Shares of Dr. Martens plc (LON:DOCS - Get Free Report) fell 1% during mid-day trading on Friday . The company traded as low as GBX 55.55 ($0.72) and last traded at GBX 56.10 ($0.73). 979,891 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 2,113,053 shares. The stock had previously closed at GBX 56.65 ($0.74).
Dr. Martens Price Performance
The firm has a market capitalization of £539.52 million, a P/E ratio of 801.43, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The business has a fifty day moving average of GBX 58.22 and a 200-day moving average of GBX 70.22. The company has a debt-to-equity ratio of 129.55, a quick ratio of 1.13 and a current ratio of 2.85.
Insider Buying and Selling at Dr. Martens
In related news, insider Lynne Weedall acquired 25,000 shares of the business's stock in a transaction dated Tuesday, August 27th. The stock was bought at an average price of GBX 74 ($0.96) per share, for a total transaction of £18,500 ($24,082.27). In other Dr. Martens news, insider Kenny Wilson bought 30,000 shares of Dr. Martens stock in a transaction dated Thursday, September 26th. The stock was bought at an average price of GBX 55 ($0.72) per share, for a total transaction of £16,500 ($21,478.78). Also, insider Lynne Weedall acquired 25,000 shares of the business's stock in a transaction that occurred on Tuesday, August 27th. The shares were purchased at an average price of GBX 74 ($0.96) per share, with a total value of £18,500 ($24,082.27). In the last ninety days, insiders bought 113,446 shares of company stock valued at $6,542,582. 4.36% of the stock is owned by corporate insiders.
About Dr. Martens
(
Get Free Report)
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Read More
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
